Raymond James Downgraded Four Medical Instruments & Supplies Stocks
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Price: $3.14 --0%
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Rating Summary:
5 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 11 | New: 17
Join SI Premium – FREE
Raymond James downgraded four Medical Instruments & Supplies stocks including:
Raymond James downgraded RTI Biologics (Nasdaq: RTIX) from Market Perform to Underperform, but share are ticking up 2.6%.
Merit Medical Systems (Nasdaq: MMSI) was downgraded from Strong Buy to Outperform. Shares are trading down approx. 1.7%.
Hospira (NYSE: HSP) was cut from Outperform to Market Perform. The stock is currently down 1%.
The biggest loser of the group is LCA-Vision (Nasdaq: LCAV), which was sliced from 'Outperform' to 'Market Perforn' Shares are now trading down ovre 6% to $5.57.
Raymond James downgraded RTI Biologics (Nasdaq: RTIX) from Market Perform to Underperform, but share are ticking up 2.6%.
Merit Medical Systems (Nasdaq: MMSI) was downgraded from Strong Buy to Outperform. Shares are trading down approx. 1.7%.
Hospira (NYSE: HSP) was cut from Outperform to Market Perform. The stock is currently down 1%.
The biggest loser of the group is LCA-Vision (Nasdaq: LCAV), which was sliced from 'Outperform' to 'Market Perforn' Shares are now trading down ovre 6% to $5.57.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades Cosmos Pharmaceuticals Corp. (3349:JP) (CSMYF) to Equalweight
- Piper Sandler Downgrades Ameris Bancorp (ABCB) to Neutral
- Raymond James Starts SpaceX (SPCX) at Strong Buy, PT Street High $800
Create E-mail Alert Related Categories
DowngradesRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
